Atlas Trials

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment

Clinical trial NCT03924193 · COMPLETED

Trial details

NCT number
NCT03924193
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Binge-Eating DisorderObesity
Start date
2019-03-25
Primary completion
2023-09-13
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.